Bond Biosciences
Discovering and developing first-in-class non-absorbed oral therapeutics to prevent and treat ion-related human diseases
Discovering and developing first-in-class non-absorbed oral therapeutics to prevent and treat ion-related human diseases
Bond Biosciences, Inc. is a privately held, clinical stage biopharmaceutical company focused on the discovery and development of first-in-class non-absorbed oral therapeutics that bind excess ions locally in the gastrointestinal (GI) tract to treat or prevent human disease.
There is no investment information
No recent news or press coverage available for Bond Biosciences.
We care about your data, and we'd love to use cookies make your experience better.